Comments
Loading...
Immunovant (NASDAQ:IMVT) Stock, Earnings Estimates, EPS, And Revenue
Immunovant reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 10
EPS Estimate
$-0.600
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Immunovant using advanced sorting and filters.
Data brought to you by Benzinga APIs
Immunovant (IMVT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-0.74 | $-0.60 | -23.3 % |
| Jun 2024 | 2024-08-06 | $-0.60 | $-0.53 | -13.2 % |
| Mar 2024 | 2024-05-29 | $-0.52 | $-0.43 | -20.9 % |
| Dec 2023 | 2024-02-12 | $-0.36 | $-0.43 | 16.3 % |
Immunovant (IMVT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Immunovant (NASDAQ:IMVT) reporting earnings?
Immunovant (IMVT) is scheduled to report earnings on February 10, 2025. The last reported earnings were for reported on November 7, 2024 for Q2.
What were the latest earnings per share (EPS) for Immunovant (NASDAQ:IMVT)?
The Actual EPS was $-0.74, which missed the estimate of $-0.60.
What were Immunovant’s (NASDAQ:IMVT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.